Zoledronic acid Stada

Recall | Medicines | 14/02/2018

The marketing authorization holder has informed its supplied customers in a letter dated February 13, 2018, that a minor contamination with Iopamidol has been detected in batch PQ0968 of the medicinal product "Zoledronic Acid STADA 4 mg/100 ml Infusion Solution". This can lead to adverse effects in correspondingly sensitized persons. Therefore, the batch is recalled as a precautionary measure.

Name of the medicinal product Zoledronsäure STADA 4mg/100ml Infusionslösung
Marketing authorisation number(s) 1-35317
Marketing authorisation holder STADA Arzneimittel GmbH
Batch number(s) PQ0968
Classification of the recall2
BASG reference number INS-640.001-2451

Further inquiry note